Novel ATP8B1 Gene Mutations in a Child with Progressive Familial Intrahepatic Cholestasis Type 1
Eun Sang Rhee1, Yu Bin Kim1, Sunghee Lee1
1Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
Insights
Progressive familial intrahepatic cholestasis (PFIC) type 1 is a severe genetic liver disorder. This report details novel mutations in a Korean patient, highlighting the importance of genetic testing for rare diseases.
Area of Science:
- Hepatology
- Medical Genetics
- Pediatric Gastroenterology
Background:
- Progressive familial intrahepatic cholestasis (PFIC) comprises severe genetic disorders causing liver dysfunction.
- PFIC necessitates early diagnosis and management to prevent cirrhosis and liver failure.
Observation:
- A Korean pediatric patient presented with intrahepatic cholestasis, steatorrhea, and growth failure.
- Serum gamma-glutamyl transferase levels were notably normal, atypical for cholestasis.
Findings:
- Novel compound heterozygous mutations, p.Glu585Ter and p.Leu749Pro, were identified in the ATP8B1 gene.
- This represents the first documented case of PFIC type 1 with these specific mutations in Korea.
Implications:
- Early genetic identification of PFIC type 1 is crucial for timely intervention.
- Understanding these novel mutations advances knowledge of ATP8B1 function in cholestasis.
- Post-liver transplant complications like steatohepatitis require further investigation in PFIC patients.
Abstract:
Progressive familial intrahepatic cholestasis (PFIC) is a group of severe genetic disorders, inherited in an autosomal recessive manner, causing cholestasis of hepatocellular origin, later progressing to biliary cirrhosis and liver failure. This is the first report of PFIC type 1 with novel compound heterozygous mutations in Korea. The patient was presented with intrahepatic cholestasis, a normal level of serum γ-glutamyl transferase, steatorrhea, and growth failure. Genetic testing of this patient revealed novel compound heterozygous mutations (p.Glu585Ter and p.Leu749Pro) in the ATP8B1 gene. After a liver transplantation at age 19 months, the patient developed severe post-transplant steatohepatitis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
ATP Synthase: Structure
ATP Synthase: Mechanism
Inborn Errors of Metabolism
Lysosomal Hydrolases
Translation
Translation Produces the Building Blocks of Life
Proteins are...


